- Scheme Category:
- Equity Scheme >
- Sectoral/Thematic Funds
NAV: ₹ ↑ 0.48%
NAV chart
SMA (Simple Moving Average)
- 50 SMA
- 100 SMA
- 200 SMA
- 400 SMA
Returns
CAGR returns till date
CAGR returns of Tata India Pharma & Healthcare Fund-Direct Plan-Growth and its peers as on 27 May, 2026| Name | YTD | 1D | 1W | 1M | 3M | 1Y | 3Y | 5Y | 7Y | 10Y |
|---|---|---|---|---|---|---|---|---|---|---|
| Tata India Pharma & Healthcare Fund-Direct Plan-Growth | 5.92% | 0.48% | 0.1% | 5.92% | 6.17% | 9.57% | 25.56% | 15.49% | 22.15% | 14.65% |
| SBI CONSUMPTION OPPORTUNITIES FUND - DIRECT PLAN - GROWTH | -7.1% | 0.32% | 0.07% | -3.19% | -2.56% | -6.47% | 10.35% | 14.32% | 15.08% | 14.98% |
| SBI ESG Exclusionary Strategy Fund - Direct Plan -Growth | -5.48% | 0.35% | 1.77% | -0.62% | -3.3% | -1.16% | 11.72% | 11.19% | 12.27% | 12.69% |
| SBI HEALTHCARE OPPORTUNITIES FUND - DIRECT PLAN -GROWTH | 10.97% | -0.1% | -0.29% | 9.23% | 7.02% | 12.45% | 26.8% | 16.8% | 23.66% | 14.43% |
| SBI INFRASTRUCTURE FUND - DIRECT PLAN - GROWTH | 4.66% | 0.53% | 2.22% | 1.89% | 5.78% | 5.31% | 21.49% | 20.51% | 18.7% | 16.71% |
| SBI PSU Fund - DIRECT PLAN - GROWTH | 4.62% | 0.33% | 2.01% | -3.23% | -4.28% | 12.5% | 32.13% | 25.63% | 19.56% | 16.62% |
Discrete returns (yearly)
| Year | 2016 | 2017 | 2018 | 2019 | 2020 | 2021 | 2022 | 2023 | 2024 | 2025 |
|---|---|---|---|---|---|---|---|---|---|---|
| Returns | -12.74% | 5.85% | -0.68% | 7.04% | 67.87% | 19.94% | -6.85% | 39.53% | 42.49% | -3.93% |
Discrete returns (monthly)
| Month | Jul 2025 | Aug 2025 | Sep 2025 | Oct 2025 | Nov 2025 | Dec 2025 | Jan 2026 | Feb 2026 | Mar 2026 | Apr 2026 |
|---|---|---|---|---|---|---|---|---|---|---|
| Returns | 3.88% | -0.49% | -1.25% | 1.74% | 0.22% | -1.64% | -5.6% | 4.93% | -6.3% | 6.93% |
Returns from spefic dates
| Description | CAGR returns from 18 Oct 2021 (Nifty 50 2021 high) | CAGR returns from 26 Sep 2024 (Nifty 50 2024 high) |
|---|---|---|
| Returns | 14.96% | 2.75% |
Portfolio
Asset allocation
| Equity | Debt | Realestate | Commodities | Cash & Equivalents |
|---|---|---|---|---|
| 99.69% | 0.00% (Arbitrage: 0.00%) | 0.00% | 0.00% | 0.31% |
Equity
| Name | Symbol / ISIN | Sector | Weight % |
|---|---|---|---|
| SUN PHARMACEUTICAL INDUSTRIES LTD | SUNPHARMA (INE044A01036) | Pharmaceuticals & Biotechnology | 10.34% |
| ABBOTT INDIA LTD | ABBOTINDIA (INE358A01014) | Pharmaceuticals & Biotechnology | 5.89% |
| DIVI LABORATORIES LTD | DIVISLAB (INE361B01024) | Pharmaceuticals & Biotechnology | 5.83% |
| HEALTHCARE GLOBAL ENTERPRISES LTD | HCG (INE075I01017) | Healthcare Services | 5.39% |
| MAX HEALTHCARE INSTITUTE LTD | MAXHEALTH (INE027H01010) | Healthcare Services | 5.14% |
| CIPLA LTD | CIPLA (INE059A01026) | Pharmaceuticals & Biotechnology | 5.10% |
| APOLLO HOSPITALS ENTERPRISE LTD | APOLLOHOSP (INE437A01024) | Healthcare Services | 4.25% |
| RAINBOW CHILDRENS MEDICARE LTD | RAINBOW (INE961O01016) | Healthcare Services | 4.23% |
| MANKIND PHARMA LTD | MANKIND (INE634S01028) | Pharmaceuticals & Biotechnology | 3.57% |
| BAYER CROPSCIENCE LTD | BAYERCROP (INE462A01022) | Fertilizers & Agrochemicals | 3.51% |
| DR REDDYS LABORATORIES LTD | DRREDDY (INE089A01031) | Pharmaceuticals & Biotechnology | 3.45% |
| LUPIN LTD | LUPIN (INE326A01037) | Pharmaceuticals & Biotechnology | 3.18% |
| FORTIS HEALTHCARE LTD | FORTIS (INE061F01013) | Healthcare Services | 3.17% |
| METROPOLIS HEALTHCARE LTD | METROPOLIS (INE112L01020) | Healthcare Services | 3.02% |
| DR. LAL PATH LABS LTD | LALPATHLAB (INE600L01024) | Healthcare Services | 2.69% |
| SYNGENE INTERNATIONAL LTD | SYNGENE (INE398R01022) | Healthcare Services | 2.64% |
| SAI LIFE SCIENCES LTD | SAILIFE (INE570L01029) | Pharmaceuticals & Biotechnology | 2.58% |
| ALKEM LABORATORIES LTD | ALKEM (INE540L01014) | Pharmaceuticals & Biotechnology | 2.45% |
| J.B.CHEMICALS & PHARMACEUTICALS LTD | JBCHEPHARM (INE572A01036) | Pharmaceuticals & Biotechnology | 2.40% |
| GLAXOSMITHKLINE PHARMACEUTICALS LTD | GLAXO (INE159A01016) | Pharmaceuticals & Biotechnology | 2.14% |
| NEULAND LABORATORIES LTD | NEULANDLAB (INE794A01010) | Pharmaceuticals & Biotechnology | 2.08% |
| AJANTA PHARMA LTD | AJANTPHARM (INE031B01049) | Pharmaceuticals & Biotechnology | 2.04% |
| GLOBAL HEALTH LTD | MEDANTA (INE474Q01031) | Healthcare Services | 2.01% |
| FDC LTD | FDC (INE258B01022) | Pharmaceuticals & Biotechnology | 1.84% |
| SANOFI INDIA LTD | SANOFI (INE058A01010) | Pharmaceuticals & Biotechnology | 1.70% |
| VIJAYA DIAGNOSTIC CENTRE LTD | VIJAYA (INE043W01024) | Healthcare Services | 1.41% |
| KRISHNA INSTITUTE OF MEDICAL SCIENCES LTD | KIMS (INE967H01025) | Healthcare Services | 1.34% |
| AUROBINDO PHARMA LTD | AUROPHARMA (INE406A01037) | Pharmaceuticals & Biotechnology | 1.20% |
| TORRENT PHARMACEUTICALS LTD | TORNTPHARM (INE685A01028) | Pharmaceuticals & Biotechnology | 1.10% |
| CORONA REMEDIES LTD | INE02ZQ01018 | Pharmaceuticals & Biotechnology | 0.75% |
| PROCTER & GAMBLE HEALTH LTD | PGHL (INE199A01012) | Pharmaceuticals & Biotechnology | 0.70% |
| PI INDUSTRIES LTD | PIIND (INE603J01030) | Fertilizers & Agrochemicals | 0.63% |
| HDFC LIFE INSURANCE CO. LTD | HDFCLIFE (INE795G01014) | Insurance | 0.62% |
| TATA CHEMICALS LTD | TATACHEM (INE092A01019) | Chemicals & Petrochemicals | 0.50% |
| SUMITOMO CHEMICAL INDIA LTD | SUMICHEM (INE258G01013) | Fertilizers & Agrochemicals | 0.39% |
| JUBILANT PHARMOVA LTD | JUBLPHARMA (INE700A01033) | Pharmaceuticals & Biotechnology | 0.34% |
| DR. AGARWALS HEALTH CARE LTD | AGARWALEYE (INE943P01029) | Healthcare Services | 0.07% |
Portfolio data is as on date 31 March, 2026
NAV history
Tata India Pharma & Healthcare Fund-Direct Plan-Growth - 30 days NAV (Net asset value) history
| Date | NAV | % change |
|---|---|---|
| 27 May, 2026 | 37.4143 | 0.48% |
| 26 May, 2026 | 37.2339 | -0.02% |
| 25 May, 2026 | 37.2432 | 0.16% |
| 22 May, 2026 | 37.1854 | -0.5% |
| 21 May, 2026 | 37.3725 | -0.01% |
| 20 May, 2026 | 37.3771 | -0.2% |
| 19 May, 2026 | 37.4522 | 0.44% |
| 18 May, 2026 | 37.2884 | 0.01% |
| 15 May, 2026 | 37.2851 | 0.29% |
| 14 May, 2026 | 37.1788 | 1.74% |
| 13 May, 2026 | 36.5437 | 0.23% |
| 12 May, 2026 | 36.4585 | -1.87% |
| 11 May, 2026 | 37.1527 | 0.64% |
| 8 May, 2026 | 36.9170 | 0.42% |
| 7 May, 2026 | 36.7620 | 0.32% |
| 6 May, 2026 | 36.6438 | 1.73% |
| 5 May, 2026 | 36.0211 | 0.07% |
| 4 May, 2026 | 35.9975 | 1.9% |
| 30 April, 2026 | 35.3246 | 0.12% |
| 29 April, 2026 | 35.2806 | 0.19% |
| 28 April, 2026 | 35.2154 | -0.3% |
| 27 April, 2026 | 35.3222 | 2.05% |
| 24 April, 2026 | 34.6137 | -1.28% |
| 23 April, 2026 | 35.0631 | 0.8% |
| 22 April, 2026 | 34.7836 | 0.18% |
| 21 April, 2026 | 34.7203 | 0.46% |
| 20 April, 2026 | 34.5617 | -0.05% |
| 17 April, 2026 | 34.5784 | 0.23% |
| 16 April, 2026 | 34.4993 | 0% |
| 15 April, 2026 | 34.4993 |
FAQ (Frequently asked questions)
What is latest/current NAV/price of Tata India Pharma & Healthcare Fund-Direct Plan-Growth?
The latest NAV of Tata India Pharma & Healthcare Fund-Direct Plan-Growth is 37.4143 as on 27 May, 2026.What are YTD (year to date) returns of Tata India Pharma & Healthcare Fund-Direct Plan-Growth?
The YTD (year to date) returns of Tata India Pharma & Healthcare Fund-Direct Plan-Growth are 5.92% as on 27 May, 2026.What are 1 year returns of Tata India Pharma & Healthcare Fund-Direct Plan-Growth?
The 1 year returns of Tata India Pharma & Healthcare Fund-Direct Plan-Growth are 9.57% as on 27 May, 2026.What are 3 year CAGR returns of Tata India Pharma & Healthcare Fund-Direct Plan-Growth?
The 3 year annualized returns (CAGR) of Tata India Pharma & Healthcare Fund-Direct Plan-Growth are 25.56% as on 27 May, 2026.What are 5 year CAGR returns of Tata India Pharma & Healthcare Fund-Direct Plan-Growth?
The 5 year annualized returns (CAGR) of Tata India Pharma & Healthcare Fund-Direct Plan-Growth are 15.49% as on 27 May, 2026.What are 10 year CAGR returns of Tata India Pharma & Healthcare Fund-Direct Plan-Growth?
The 10 year annualized returns (CAGR) of Tata India Pharma & Healthcare Fund-Direct Plan-Growth are 15.49% as on 27 May, 2026.